Pfizer (Switzerland)

Institution (Company)

Homepage Wikipedia ROR

Also Known As

Pfizer (Switzerland)

164

Publications

2.7K

Citations

Authors

Concepts

About

Pfizer (Switzerland) is a company institution in Zurich, Switzerland known for medicine, oncology, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	11	1.1K
2	Health Sciences	2	2	596
3	Arts	1	1	16
4	Business	1	1	16
5	Management	1	1	16

Pfizer (Switzerland)

164

Publications

2.7K

Citations

Page 1

	Year	Citations
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, The Lancet Oncology Neoadjuvant TherapySquamous Cell CarcinomaMedicineHead And Neck CancerCancer Treatment	2021	582
Enteric coated HPMC capsules designed to achieve intestinal targeting Ewart T. Cole, Robert A. Scott, Alyson Connor, International Journal of Pharmaceutics Gut BarrierGastroenterologyBiomedical EngineeringHpmc Capsules	2002	236
Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent Paolo Ferrari, P Weidmann, Sidney Shaw, The American Journal of Medicine ObesityNutritionHypertensionMetabolic SyndromeMetabolic Disorder	1991	205
In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules Ewart T. Cole, Robert A. Scott, Dominique Cadé, Pharmaceutical Research Pharmaceutical ScienceVivo Pharmacoscintigraphic EvaluationMedicineTopical DrugGelatin Capsules	2004	62
910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) Ezra E.W. Cohen, Robert L. Ferris, Amanda Psyrri, Annals of Oncology	2020	40
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis David T. Rubin, Walter Reinisch, Thomas Greuter, Therapeutic Advances in Gastroenterology	2021	35
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Bruce E. Sands, Journal of Crohn s and Colitis	2024	31
Efficacy and safety of etrasimod, a sphingosine 1‐phosphate receptor modulator, in adults with moderate‐to‐severe atopic dermatitis (<scp>ADVISE</scp>) Jonathan I. Silverberg, Robert Bissonnette, Leon Kircik, Journal of the European Academy of Dermatology and Venereology	2023	24
Unaltered insulin sensitivity during calcium channel blockade with amlodipine Paolo Ferrari, Daniel Giachino, P Weidmann, European Journal of Clinical Pharmacology Insulin ManagementPhysiologyDiabetesUnaltered Insulin SensitivityElectrophysiology	1991	22
Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland Dennis Mircsof Cardiology and Therapy	2020	18

Page 1